Michael Logerfo

Sagent Holdings Co. operates as an injectable pharmaceutical company that develops and sources products which it sells in the U.S. through its sales and marketing team. It primarily focuses on generic injectable pharmaceuticals. The company currently offers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. Sagent Holdings was founded in 2006 and is headquartered in Schaumburg, IL.

Phillips Nizer LLP provides legal services. The company was founded by Louis Phillips and Louis Nizer in 1926 and is headquartered in New York, NY.

Ferro Labella & Zucker LLC provides legal services. The private company is based in Hackensack, NJ.

Sagent Pharmaceuticals, Inc. engages in the developing, manufacturing, and marketing of medical products. It offers injectable products such as amikacin sulfate, ampicillin and sulbactam, cefazolin, piperacillin and tazobactam, and vancomycin hydrochloride. The company was founded by Jeffrey M. Yordon in 2006 and is headquartered in Schaumburg, IL.

Kuwait Saudi Pharmaceutical Industries Co. SAK manufactures pharmaceutical products. It offers oral solid, oral liquids, semi solid, large volume parenteral, and small volume parenteral medicines, and distributions. The company was founded by Abdul Rahman Abdullah Al Awadi in 1994 and is headquartered in Kuwait City.